Capabilities by Region

Greenhill is active in all major markets with meaningful corporate advisory activity, including in North America, Europe,  Asia, and Australia.

Recent Transactions

21-Nov-11
$689 million
Australia flag
Target: 

iNova Pharmaceuticals

United States flag
Acquiror: 
Valeant Pharmaceuticals

Advised Archer Capital and Ironbridge Capital on the sale of iNova Pharmaceuticals, a leading pharmaceuticals company that sells and distributes a range of prescription and over-the-counter products in Australia, New Zealand, Asia and Southern Africa, to Valeant Pharmaceuticals

17-Nov-11
$1.5 billion
United Kingdom flag
Target: 

Northern Rock

United Kingdom flag
Acquiror: 
Virgin Money

Advised Virgin Money, a financial services provider, on the acquisition of Northern Rock, a UK retail mortgage and savings bank, from UK Financial Investments Ltd, which manages the UK Government’s investments in financial institutions

08-Dec-11
$NA
United States flag
Target: 

US Department of Energy

Advised Herb Allison in an independent review of a $35.9 billion energy loan portfolio

13-Dec-11
$345 million
United States flag
Target: 

Cabot Microelectronics Corporation

Advised Cabot Microelectronics Corporation on its new capital management initiative, including a leveraged recapitalization via a special dividend

16-Dec-11
$NA
United States flag
Target: 

ISTA Pharmaceuticals, Inc.

Advised ISTA Pharmaceuticals, an ophthalmic pharmaceutical company, on its defense against an unsolicited offer from Valeant Pharmaceuticals and on its review of strategic alternatives

Pages

show all